Research programme: protein kinase inhibitors - Asana BioSciencesAlternative Names: ASN-006; ASN-007; ASN007A
Latest Information Update: 01 May 2016
At a glance
- Originator Asana BioSciences
- Class Antineoplastics; Small molecules
- Mechanism of Action Focal adhesion protein-tyrosine kinase inhibitors; Mitogen-activated protein kinase inhibitors; Src-Family kinase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer